|
Q-1097
|
Tuesday, April 21, 2026 |
With regard to the government's approach on medical assistance in dying and the term "mental illness" as used in subsection 241.2(2.1) of the Criminal Code, introduced through Bill C-7 in 2021, which forms the basis of the current temporary exclusion from medical assistance in dying for persons whose sole underlying medical condition is a mental illness, and which is scheduled to lift on March 17, 2027: (a) what is the definition of "mental illness" as used in subsection 241.2(2.1), and in which statute, regulation, guidance document, legal instrument, or other authority is that definition established; (b) if "mental illness" is not defined in the Criminal Code or any other federal law or instrument, what clinical, diagnostic, legal, or policy authority does the government rely upon to determine the scope of that term for the purposes of subsection 241.2(2.1); (c) has the government, since the May 2022 final report of the Expert Panel on Medical Assistance in Dying and Mental Illness, adopted, endorsed, or relied upon any formal definition or interpretation of "mental illness" for the purposes of subsection 241.2(2.1), and, if so, what is that definition or interpretation, by what authority was it adopted, and on what date; (d) what specific clinical conditions does the government consider to fall within the meaning of "mental illness" for the purposes of subsection 241.2(2.1), and what clinical or legal source does the government rely upon for each; (e) what specific clinical conditions does the government consider to fall outside the meaning of "mental illness" for the purposes of subsection 241.2(2.1), such that a person whose sole underlying medical condition is one of those conditions would not be subject to the exclusion, and what clinical or legal source does the government rely upon for each; (f) has the Department of Justice, the Department of Health, or any other federal department or agency produced any legal analysis, policy analysis, or formal opinion on the scope of the term "mental illness" in subsection 241.2(2.1), including which conditions are captured and which are not, and, if so, what are the dates and titles of those documents; and (g) before the exclusion is scheduled to lift on March 17, 2027, by what specific mechanism, including whether legislative definition, regulatory guidance, clinical practice standards, or judicial interpretation, will the boundaries of the term "mental illness" be established, and what steps has the government taken, or does it plan to take, to ensure consistent interpretation and application of that term across all provinces and territories? |
Awaiting response |
Monday, June 8, 2026 |
|
Q-1096
|
Tuesday, April 21, 2026 |
With regard to federal expenditures related to medical assistance in dying, palliative care, and disability supports: (a) beyond the budget 2021 allocation previously disclosed for medical assistance in dying related training, resources, and tools, what federal expenditures have been incurred specifically in connection with medical assistance in dying, including the administration and operation of the federal medical assistance in dying monitoring regime, regulatory administration, secretariat support for the Federal-Provincial-Territorial Assistant Deputy Minister Committee on Medical Assistance in Dying, legal costs related to medical assistance in dying legislation or litigation, and any other departmental expenditures attributable to medical assistance in dying, broken down by expenditure category and fiscal year; (b) of the funding previously cited by the government under the budget 2017 home and community care allocation and the Aging With Dignity bilateral agreements, what portion was directed exclusively to palliative care, as distinct from home care, long-term care, and other continuing care priorities, broken down by fiscal year and province or territory; (c) what total federal expenditure has been directed through Health Canada's Health Care Policy and Strategies Program specifically to palliative care access, hospice infrastructure, and palliative care training since fiscal year 2021-22, broken down by initiative or recipient and by fiscal year, and, separately, what total has been directed specifically to medical assistance in dying related activities through the same program over the same period; (d) what total federal expenditure has been directed specifically toward community-based disability supports and independent living programs since fiscal year 2021-22, broken down by responsible department, program or initiative, and fiscal year; and (e) has the government conducted any comparative analysis of federal investment in medical assistance in dying related infrastructure, palliative care access, and community-based disability supports since 2016, and, if so, what are the dates and titles of those analyses? |
Awaiting response |
Monday, June 8, 2026 |
|
Q-1095
|
Tuesday, April 21, 2026 |
With regard to Track 2 medical assistance in dying provisions under section 241.2(3) of the Criminal Code since the passage of Bill C-7 on March 17, 2021: (a) how many Track 2 medical assistance in dying provisions occurred in each calendar year from 2021 to 2024, broken down by province and territory; (b) what categories of underlying medical condition are recorded in the federal medical assistance in dying monitoring data for Track 2 provisions; (c) for each category identified in (b), how many Track 2 medical assistance in dying provisions occurred from 2021 to 2024, broken down by year and by province or territory; (d) of the Track 2 medical assistance in dying recipients from 2021 to 2024 who self-identified as having a disability, how many were women, broken down by year and by province or territory; (e) for each year from 2021 to 2024, how many Track 2 medical assistance in dying requests were assessed as ineligible, broken down by province or territory and by reason for ineligibility, including, if tracked, cases in which the irremediability criterion was found not to have been met; and (f) has the government, or any federally-funded body, conducted any audit, review, evaluation, or other assessment of whether the irremediability criterion is being applied consistently in Track 2 cases, including whether treatment and support options have been adequately considered before a finding of irremediability is made, and, if so, what are the dates and titles of those documents and what were the findings or conclusions of those documents? |
Awaiting response |
Monday, June 8, 2026 |
|
Q-1094
|
Tuesday, April 21, 2026 |
With regard to the government's response to the Concluding Observations on Canada adopted by the United Nations Committee on the Rights of Persons with Disabilities on March 18, 2025, and the recommendation for the Government of Canada to repeal the 2027 expansion of medical assistance in dying to persons whose sole underlying medical condition is a mental illness, and with respect to any equality rights analysis of Track 2 medical assistance in dying provisions under section 15 of the Canadian Charter of Rights and Freedoms: (a) has the government prepared a formal written response to the Committee's medical assistance in dying related recommendations, and, if so, what is the date of that response or its expected release date, and, if not, why not; (b) what interdepartmental or intergovernmental meetings have occurred since March 18, 2025, to consider the medical assistance in dying related recommendations in the Concluding Observations, and, for each meeting, what was the date, which departments or agencies participated, and what decisions, action items, or next steps were recorded; (c) has the Department of Justice conducted or commissioned any legal analysis of the consistency of Track 2 medical assistance in dying with Articles 10 and 15 of the Convention on the Rights of Persons with Disabilities since March 18, 2025, and, if so, what are the dates, titles, and findings of each; (d) has the Department of Justice conducted or commissioned any section 15 Charter analysis of the Track 2 medical assistance in dying provisions since the passage of Bill C-7 in 2021, and, if so, what are the dates, titles, and findings of each, and, if not, why not; (e) has the Department of Justice or any other federal department or agency produced any internal report, memorandum, briefing note, or evaluation regarding the implications of the decision in Truchon v. Attorney General of Canada for the equality rights of persons with disabilities nationally, and, if so, what are the dates and titles of each of those documents; and (f) since March 18, 2025, what consultations, meetings, or correspondence has the government had with disability organizations specifically regarding the medical assistance in dying related recommendations in the Concluding Observations, and, for each, what was the date, which organizations participated, and what follow-up action, if any, was taken? |
Awaiting response |
Monday, June 8, 2026 |
|
Q-836
|
Tuesday, February 3, 2026 |
With regard to the government's stated objective that provinces and territories implement standards and enhance coordination and oversight mechanisms related to medical assistance in dying and medical assistance in dying where a mental disorder is the sole underlying condition (MD-SUMC): (a) which provinces and territories have formally adopted the federal Model Practice Standard for Medical Assistance in Dying, in whole or in part, and what jurisdiction-specific modifications, if any, have been made; (b) what mechanisms exist in each province and territory for oversight and quality assurance of medical assistance in dying cases, including any mandatory review processes; (c) which provinces or territories have implemented enhanced oversight specific to complex Track 2 cases, and which have implemented enhanced oversight specific to MD-SUMC cases; (d) for each province and territory, does oversight include prospective case review prior to provision of medical assistance in dying, retrospective review following provision, or both; (e) what coordination mechanisms exist to ensure consistent application of safeguards across jurisdictions, including for cases involving fluctuating capacity or suicidality; and (f) what are the details of all federal-provincial-territorial meetings, working groups, or formal agreements that have taken place since January 1, 2024, on MD-SUMC readiness, including the dates, the participants, the agendas, and any deliverables or decisions made? |
Answered |
Monday, March 23, 2026 |
|
Q-835
|
Tuesday, February 3, 2026 |
With regard to the collection and monitoring of medical assistance in dying data under the Regulations for the Monitoring of Medical Assistance in Dying: (a) what specific data elements are collected at the federal level for each medical assistance in dying request and provision, including any data fields related to socio-economic status, access to health services, or social vulnerability; (b) what data elements are collected by each province and territory beyond the federal minimum requirements, including whether each jurisdiction collects any direct measures of social determinants of health such as housing status, income insecurity, social supports, or access to mental health care; (c) what changes, if any, have been made to medical assistance in dying data collection instruments, reporting forms, or guidance documents since January 29, 2024; (d) has the government proposed, drafted, or consulted on further amendments to the monitoring regulations since January 29, 2024, and, if so, what amendments and timelines are being considered; and (e) what assessment has been conducted by Health Canada regarding the adequacy of current medical assistance in dying monitoring to detect coercion, inducement, or structural vulnerability in medical assistance in dying requests, particularly for potential medical assistance in dying where a mental disorder is the sole underlying medical condition cases? |
Answered |
Monday, March 23, 2026 |
|
Q-834
|
Tuesday, February 3, 2026 |
With regard to federal preparations for the planned expansion of medical assistance in dying to cases where a mental disorder is the sole underlying medical condition (MD-SUMC): (a) how many individuals have, as of February 1, 2026, registered for medical assistance in dying-related training programs funded in whole or in part by the government, including the Canadian MAiD Curriculum; (b) of the individuals in (a), how many have completed all training requirements, in total and broken down by profession (physician, nurse practitioner, psychiatrist, other) and by province or territory; (c) how many individuals have completed any training specifically related to MD-SUMC assessment or consultation, in total and broken down by profession and province or territory; (d) what criteria, competencies, or learning objectives does the government use to determine whether a practitioner is adequately trained to assess MD-SUMC requests; (e) how many psychiatrists have indicated willingness to provide consultation for MD-SUMC requests, broken down by province or territory; and (f) what are the details of all federal funding, contracts, or contribution agreements which have been issued since January 1, 2024, to support medical assistance in dying-related training for MD-SUMC, including, for each, the amounts, recipients, objectives, and timelines? |
Answered |
Monday, March 23, 2026 |
|
Q-833
|
Tuesday, February 3, 2026 |
With regard to the government's commitment to undertake research providing insights into the reasons why people seek medical assistance in dying and the views and experiences of medical assistance in dying among key populations: (a) what studies, surveys, or research projects have been initiated, funded, commissioned, or completed by the government since January 1, 2024, on the reasons for medical assistance in dying requests; (b) for each study, survey, or research project in (a), what were the results or findings; (c) what variables related to social determinants of health and structural vulnerability were included in each study, including, but not limited to, income insecurity, housing insecurity, disability supports, access to mental health care, and social isolation; (d) what research or tools have been developed to detect or assess coercion, inducement, or "choice under constraint" in medical assistance in dying requests, including for Track 2 cases; and (e) what findings exist on the relationship between medical assistance in dying requests and socio-economic deprivation or unmet social needs? |
Answered |
Monday, March 23, 2026 |
